From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.
The Scottish technology firm has raised a second tranche of investment to further grow its business in the field of early disease detection ...
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...
A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...
Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...
Our gut microbiome has a huge influence on our overall health, but we haven't been clear on the specific bacteria with good ...
Given the recent interest in longevity, antiaging supplements are rising in popularity, and among them, NAD+ is at the ...
Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...
Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly ...
Sequencing diverse populations revealed over 41,000 transcripts missing in Eurocentric references, exposing ancestry bias ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback